In Vitro and In Vivo Assessment of the Ability of Adeno‐Associated Virus–Brain‐Derived Neurotrophic Factor to Enhance Spiral Ganglion Cell Survival Following Ototoxic Insult
Authors:
- 1 August 2002
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 112 (8) , 1325-1334
Abstract
Objectives/Hypothesis Auditory dysfunction following ototoxic insult results from loss of cochlear hair cells. Secondary degeneration of auditory neurons ensues from withdrawal of neurotrophic support from hair cells and can be prevented with administration of neurotrophins. Administration of adeno‐associated virus containing the gene for brain‐derived neurotrophic factor will promote spiral ganglion neuron survival after the destruction of hair cells.Methods Prevention of aminoglycoside‐induced spiral ganglion neuron loss through the expression of brain‐derived neurotrophic factor mediated by means of the adeno‐associated virus was tested in vitro in cochlear explants and in vivo in mammalian cochlea.Results Neuronal survival was significantly enhanced in adeno‐associated virus–brain‐derived neurotrophic factor transfected rat cochlear explants compared with control samples (30% vs. 19%, P <.05) following exposure to aminoglycoside. Following deafening with aminoglycoside and loop diuretic and introduction of adeno‐associated virus–brain‐derived neurotrophic factor through osmotic minipump, the experimental group of animals infused with adeno‐associated virus–brain‐derived neurotrophic factor displayed enhanced spiral ganglion neuron survival in the basal turn of the cochlea when compared with the control group infused with adeno‐associated virus containing green fluorescent protein reporter gene.Conclusions Administration of adeno‐associated virus–brain‐derived neurotrophic factor enhances spiral ganglion neuron survival following ototoxic exposure in vitro and in vivo. These studies lay the groundwork for further exploration of its application as an adjunct therapy for patients undergoing cochlear implantation because the success of implantation depends directly on the population of neurons available for electrical stimulation.Keywords
This publication has 46 references indexed in Scilit:
- Cochlear Function and Transgene Expression in the Guinea Pig Cochlea, Using Adenovirus- and Adeno-Associated Virus-Directed Gene TransferHuman Gene Therapy, 2001
- Cochlear Gene Delivery through an Intact Round Window Membrane in MouseHuman Gene Therapy, 2001
- Safety of Adeno-Associated Virus as Cochlear Gene Transfer Vector: Analysis of Distant Spread Beyond Injected CochleaeMolecular Therapy, 2000
- Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicityGene Therapy, 2000
- Cochlear Gene Therapy2000
- Hair Cell Protection from Aminoglycoside Ototoxicity by Adenovirus-Mediated Overexpression of Glial Cell Line-Derived Neurotrophic FactorHuman Gene Therapy, 1999
- Inner Ear Transgene Expression after Adenoviral Vector Inoculation in the Endolymphatic SacHuman Gene Therapy, 1999
- Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virusGene Therapy, 1998
- Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivoNeuroscience Letters, 1996
- Quantitative Relationships of the Ototoxic Interaction of Kanamycin and Ethacrynic AcidJAMA Otolaryngology–Head & Neck Surgery, 1979